Diabetes and Endocrinology

Latest News

California Selects Generic Company Civica Rx as Insulin Partner
California Selects Generic Company Civica Rx as Insulin Partner

March 22nd 2023

CalRx will work with Civica to provide the most commonly used short- and long-acting insulins at planned prices of no more than $30 a vial and $55 for a box of five pre-filled pens.

Sanofi Slashes Lantus List Price by 78%
Sanofi Slashes Lantus List Price by 78%

March 18th 2023

Novo Nordisk Cuts Price on Several Insulin Products by 75%
Novo Nordisk Cuts Price on Several Insulin Products by 75%

March 14th 2023

FDA Accepts sNDA for Jardiance in Children 10 to 17 with Diabetes
FDA Accepts sNDA for Jardiance in Children 10 to 17 with Diabetes

March 8th 2023

Updated: Lilly Cuts Prices of Some Insulins and Caps Out-of-Pocket Costs
Updated: Lilly Cuts Prices of Some Insulins and Caps Out-of-Pocket Costs

March 2nd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.